Article details

New oral pill beats previous alternatives and shows 8% weight loss in clinical trials

Actualitate EN 27 Feb 2026, 16:24 Source: EuroNews
Read the original article Back to feed

Eli Lilly’s new oral pill, orforglipron, led to up to 8% weight loss in clinical trials, outperforming existing oral semaglutide alternatives.

Published 3 months ago - updated 3 months ago